GWM
HRMY icon

Gilpin Wealth Management’s Harmony Biosciences HRMY Stock Holding History

Gilpin Wealth Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$158 Hold
4
– – ﹤0.01% 1201
2026
Q2 		$146 Buy
+4
New +$126 ﹤0.01% 983
2026
Q1 		– Sell
-2
Closed -$75 – 1033
2025
Q4 		$75 Buy
+2
New +$66 ﹤0.01% 881

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Gilpin Wealth Management's HRMY Position: Q3 2026 in Review

Gilpin Wealth Management held its Harmony Biosciences (HRMY) position steady in Q3 2026 at 4 shares worth $158. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Gilpin Wealth Management first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Gilpin Wealth Management held 4 shares of Harmony Biosciences worth $158 as of Q3 2026.
  • Gilpin Wealth Management left its Harmony Biosciences share count unchanged in Q3 2026.
  • Harmony Biosciences made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1201 holding.
  • Gilpin Wealth Management first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.